Impact of cause of death adjudication on the results of the European prostate cancer screening trial

Contemporary accuracy of death certificates for coding prostate cancer as a cause of death: Is reliance on death certification good enough? A comparison with blinded review by an independent cause of death evaluation committee

(2016) Emma L Turner et al.   BRITISH JOURNAL OF CANCER

Standardisation of information submitted to an endpoint committee for cause of death assignment in a cancer screening trial – lessons learnt from CAP (Cluster randomised triAl of PSA testing for Prostate cancer)

(2015) Naomi J Williams et al.   BMC Medical Research Methodology

Global surveillance of cancer survival 1995–2009: analysis of individual data for 25 676 887 patients from 279 population-based registries in 67 countries (CONCORD-2)

(2015) Claudia Allemani et al.   LANCET

Impacts of a population-based prostate cancer screening programme on excess total mortality rates in men with prostate cancer: a randomized controlled trial

(2014) P. J. van Leeuwen et al.   JOURNAL OF MEDICAL SCREENING

Screening and prostate cancer mortality: results of the European Randomised Study of Screening for Prostate Cancer (ERSPC) at 13 years of follow-up

(2014) Fritz H Schröder et al.   LANCET

Excess all-cause mortality in the evaluation of a screening trial to account for selective participation

(2013) Ries Kranse et al.   JOURNAL OF MEDICAL SCREENING

Accuracy of p53 Codon 72 Polymorphism Status Determined by Multiple Laboratory Methods: A Latent Class Model Analysis

(2013) Stephen D. Walter et al.   PLoS One

Prostate Cancer Screening in the Randomized Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial: Mortality Results after 13 Years of Follow-up

(2012) G. L. Andriole et al.   JNCI-Journal of the National Cancer Institute

Temporal Trends in Cause of Death Among Swedish and US Men with Prostate Cancer

(2012) M. M. Epstein et al.   JNCI-Journal of the National Cancer Institute

Prostate-Cancer Mortality at 11 Years of Follow-up

(2012) Fritz H. Schröder et al.   NEW ENGLAND JOURNAL OF MEDICINE

High accuracy of Swedish death certificates in men participating in screening for prostate cancer: A comparative study of official death certificates with a cause of death committee using a standardized algorithm

(2011) Rebecka Godtman et al.   SCANDINAVIAN JOURNAL OF UROLOGY AND NEPHROLOGY

Does the source of death information affect cancer screening efficacy results? A study of the use of mortality review versus death certificates in four randomized trials

(2010) V Paul Doria-Rose et al.   Clinical Trials

Blinded and uniform causes of death verification in cancer screening: A major influence on the outcome of a prostate cancer screening trial?

(2010) S.J. Otto et al.   EUROPEAN JOURNAL OF CANCER

Outcomes in Localized Prostate Cancer: National Prostate Cancer Register of Sweden Follow-up Study

(2010) P. Stattin et al.   JNCI-Journal of the National Cancer Institute

Overdiagnosis in Cancer

(2010) H. G. Welch et al.   JNCI-Journal of the National Cancer Institute

Screening and Prostate-Cancer Mortality in a Randomized European Study

(2009) Fritz H. Schröder et al.   NEW ENGLAND JOURNAL OF MEDICINE

Use of latent class models to accommodate inter-laboratory variation in assessing genetic polymorphisms associated with disease risk

(2008) Stephen D Walter et al.   BMC GENETICS

Screening, Treatment, and Prostate Cancer Mortality in the Seattle Area and Connecticut: Fifteen-year Follow-up

(2008) Grace Lu-Yao et al.   JOURNAL OF GENERAL INTERNAL MEDICINE

Reliability of death certificates in prostate cancer patients

(2008) Katja Fall et al.   SCANDINAVIAN JOURNAL OF UROLOGY AND NEPHROLOGY